Development of strategies for the use of anti-growth factor treatments. (Record no. 15750104)

MARC details
000 -LEADER
fixed length control field 01332 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515000047.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200511s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1351-0088
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1677/erc.1.01004
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Jones, H E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20051111
245 00 - TITLE STATEMENT
Title Development of strategies for the use of anti-growth factor treatments.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Endocrine-related cancer
Date of publication, distribution, etc. Jul 2005
300 ## - PHYSICAL DESCRIPTION
Extent S173-82 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Proliferation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element ErbB Receptors
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gefitinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Signal Transduction
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gee, J M W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Taylor, K M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barrow, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Williams, H D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rubini, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nicholson, R I
773 0# - HOST ITEM ENTRY
Title Endocrine-related cancer
Related parts vol. 12 Suppl 1
-- p. S173-82
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1677/erc.1.01004">https://doi.org/10.1677/erc.1.01004</a>
Public note Available from publisher's website

No items available.